90
Participants
Start Date
August 29, 2024
Primary Completion Date
May 30, 2026
Study Completion Date
December 30, 2026
Aerobic exercise
The intervention is exercise and there are no drugs or devices used in this trial. The exercise consists of two intensity levels of a 30-minute aerobic exercise intervention with both arms crossing over to both conditions: low intensity exercise (60-70% of estimated maximum heart rate (EMRH)) and moderate-vigorous intensity exercise (75-85% of EMHR).
RECRUITING
Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV, Las Vegas
University of Nevada, Las Vegas
OTHER